Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 17, Issue 11, Pages 1463-1473
Publisher
Oxford University Press (OUP)
Online
2015-03-21
DOI
10.1093/neuonc/nov041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noninvasive Monitoring of Pharmacodynamics and Kinetics of a Death Receptor 5 Antibody and Its Enhanced Apoptosis Induction in Sequential Application with Doxorubicin
- (2015) Thomas G Weber et al. NEOPLASIA
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
- (2014) W Fiskus et al. LEUKEMIA
- LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
- (2013) J Ding et al. BRITISH JOURNAL OF CANCER
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
- (2013) Krishna P.L. Bhat et al. CANCER CELL
- Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells
- (2013) Shauna N. Vasilatos et al. CARCINOGENESIS
- Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2
- (2013) Emanuela Toffolo et al. JOURNAL OF NEUROCHEMISTRY
- p73 Expression Is Regulated by RNPC1, a Target of the p53 Family, via mRNA Stability
- (2012) W. Yan et al. MOLECULAR AND CELLULAR BIOLOGY
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription
- (2012) Chaitali Tophkhane et al. PLoS One
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells
- (2011) Antonio Adamo et al. NATURE CELL BIOLOGY
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Identification of biomarkers associated with metastastic breast cancer to bone by immunohistochemistry on tissue microarrays.
- (2010) I Nasir et al. CANCER RESEARCH
- Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma
- (2010) Michael D. Blough et al. JOURNAL OF NEURO-ONCOLOGY
- The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells
- (2010) Takashi Shingu et al. NEURO-ONCOLOGY
- TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
- (2008) R. Tomasini et al. GENES & DEVELOPMENT
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- LSD1: oxidative chemistry for multifaceted functions in chromatin regulation
- (2008) Federico Forneris et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search